Beranda › Kanker Metastatik › California › Orange
Uji klinis Kanker Metastatik di Orange, CA
20 studi untuk Kanker Metastatik mencari peserta di lokasi sekitar Orange (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Children's Hospital of Orange County, Orange
- Saint Joseph Hospital - Orange, Orange
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Menerima pesertaFase 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Menerima pesertaFase 1/2
- University of California Irvine, Orange
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Menerima pesertaFase 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Menerima pesertaFase 2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- UC Irvine Health, Orange
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Menerima pesertaFase 1/2
- UCI Medical Center, Orange
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Menerima pesertaFase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Menerima pesertaFase 1/2
- UC IRVINE Health, Orange
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Menerima pesertaFase 1/2
- University of California-Irvine Medical Center ( Site 0016), Orange
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Menerima pesertaFase 1
- University of California - Irvine, Orange
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Menerima pesertaFase 1/2
- Crinetics Study Site, Orange
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Menerima pesertaFase 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Menerima pesertaFase 3
- Research Site, Orange
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Research Site, Orange
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Menerima pesertaFase 1/2
- University of California Irvine Medical Center, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Menerima pesertaFase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- Stern Center for Cancer Clinical Trials and Research, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Orange
Uji klinis Kanker Metastatik di kota lain
- Houston, TX104 studi
- New York City, NY93 studi
- Nashville, TN70 studi
- Boston, MA63 studi
- Los Angeles, CA57 studi
- St. Louis, MO54 studi
- Arlington, VA53 studi
- Philadelphia, PA46 studi
- Chicago, IL45 studi
- San Antonio, TX44 studi
- Washington, DC43 studi
- Dallas, TX42 studi
Studi lain di Orange
- Kanker Paru Non-Sel Kecil25 studi
- Kanker Kolorektal16 studi
- Kanker Ovarium16 studi
- Kanker Pankreas15 studi
- Melanoma14 studi
- Kanker Hati (Karsinoma Hepatoseluler)14 studi
- Kanker Payudara14 studi
- Kanker Paru14 studi
- Kanker Prostat14 studi
- Kanker Lambung13 studi
- Kanker (semua jenis)13 studi
- Leukemia Mieloid Akut13 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.